Free Newsletter
Software culls insurance claims for subjects
Clinical informatics meets patient data in a solution that targets the lagging subject enrollment of clinical trials. The software capitalizes on the ability of top-ranking investigators to enroll patients more quickly than most others, and it taps into database of prospective trial subjects.
Subject-recruitment solution provider Acurian and informatics company i3 are working to beef up the Acurian patient database so it provides statistics that will help sponsors identify trial sites with access to specific patient populations.
The i3 database relating to private insurance claims can help sponsors identify candidate investigators throughout the U.S. and rank them according to the number of available patients who match study criteria. Some 50 million patients have self-reported ailments and expressed an interest in clinical trial opportunities via the Acurian.com Internet site and affiliated sources, Acurian says.
- here's the i3 release
Related Articles:
Site helps visitors find trials
Acurian taps into web, viral marketing
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




